A Cytoplasmic Inhibitor of the JNK Signal Transduction Pathway

Martin Dickens(Boston Children's Hospital), Jeffrey S. Rogers(Boston Children's Hospital), Julie Cavanagh(Boston Children's Hospital), Art Raitano(Boston Children's Hospital), Zhengui Xia(Boston Children's Hospital), J Halpern(Boston Children's Hospital), Michael E. Greenberg(Boston Children's Hospital), Charles L. Sawyers(Boston Children's Hospital), Roger J. Davis(Boston Children's Hospital)
Science
August 1, 1997
Cited by 678

Abstract

The c-Jun amino-terminal kinase (JNK) is a member of the stress-activated group of mitogen-activated protein (MAP) kinases that are implicated in the control of cell growth. A murine cytoplasmic protein that binds specifically to JNK [the JNK interacting protein-1 (JIP-1)] was characterized and cloned. JIP-1 caused cytoplasmic retention of JNK and inhibition of JNK-regulated gene expression. In addition, JIP-1 suppressed the effects of the JNK signaling pathway on cellular proliferation, including transformation by the Bcr-Abl oncogene. This analysis identifies JIP-1 as a specific inhibitor of the JNK signal transduction pathway and establishes protein targeting as a mechanism that regulates signaling by stress-activated MAP kinases.


Related Papers

No related papers found

Powered by citation graph analysis